Mary Margaret Chren

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma
    Mary Margaret Chren
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94143 0808, USA
    J Invest Dermatol 133:1188-96. 2013
  2. pmc The contribution of health services research to improved dermatologic care
    Mary Margaret Chren
    Department of Dermatology, University of California, San Francisco, San Francisco, California 94143 0808, USA
    J Invest Dermatol 132:1003-7. 2012
  3. pmc The Skindex instruments to measure the effects of skin disease on quality of life
    Mary Margaret Chren
    Department of Dermatology, University of California at San Francisco, San Francisco, CA 94143 0808, USA
    Dermatol Clin 30:231-6, xiii. 2012
  4. pmc Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study
    Mary Margaret Chren
    Health Services Research and Development Service, Department of Veterans Affairs, San Francisco VA Medical Center 151R, 4150 Clement St, San Francisco, CA 94121, USA
    Arch Dermatol 147:540-6. 2011
  5. pmc Interpretation of quality-of-life scores
    Mary Margaret Chren
    Department of Dermatology, University of California, San Francisco, San Francisco, California, USA
    J Invest Dermatol 130:1207-9. 2010
  6. ncbi request reprint Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma
    Mary Margaret Chren
    Dermatology Service, San Francisco Veterans Affairs Medical Center and the Department of Veterans Affairs, San Francisco, California 94121, USA
    J Invest Dermatol 127:1351-7. 2007
  7. ncbi request reprint Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma
    Tina Chen
    School of Medicine, University of California at San Francisco, San Francisco, USA
    Arch Dermatol 143:1386-92. 2007
  8. ncbi request reprint Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic
    Mary Margaret Chren
    Dermatology Service, Research Enhancement Award Program of the Health Services Research and Development Service, Department of Veterans Affairs, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Med Care 42:1019-26. 2004
  9. ncbi request reprint Narrative review: the promotion of gabapentin: an analysis of internal industry documents
    Michael A Steinman
    San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California 94143, USA
    Ann Intern Med 145:284-93. 2006
  10. ncbi request reprint Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease
    ANN M O'HARE
    Department of Medicine, VA Medical Center, San Francisco, San Francisco, CA 94121, USA
    Clin J Am Soc Nephrol 1:297-304. 2006

Research Grants

  1. COMPREHENSIVE OUTCOME OF NONMELANOMA SKIN CANCER
    Mary Margaret Chren; Fiscal Year: 2005
  2. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2006
  3. Patient-Oriented Research in Skin Diseases
    Mary Margaret Chren; Fiscal Year: 2007
  4. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2007
  5. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2009
  6. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2009

Collaborators

Detail Information

Publications46

  1. pmc Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma
    Mary Margaret Chren
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94143 0808, USA
    J Invest Dermatol 133:1188-96. 2013
    ..These data indicate that common treatments for NMSCs were at least 95% effective, and further studies are needed to guide therapeutic choices for different clinical subgroups...
  2. pmc The contribution of health services research to improved dermatologic care
    Mary Margaret Chren
    Department of Dermatology, University of California, San Francisco, San Francisco, California 94143 0808, USA
    J Invest Dermatol 132:1003-7. 2012
    ..The paper also addresses some of the political and systematic challenges for health services research overall, and for individual investigators and program leaders...
  3. pmc The Skindex instruments to measure the effects of skin disease on quality of life
    Mary Margaret Chren
    Department of Dermatology, University of California at San Francisco, San Francisco, CA 94143 0808, USA
    Dermatol Clin 30:231-6, xiii. 2012
    ..Studies of quality of life in patients with nonmelanoma skin cancer are described to illustrate the use of Skindex to understand quality of life and to compare effectiveness of different treatments for this highly prevalent condition...
  4. pmc Recurrence after treatment of nonmelanoma skin cancer: a prospective cohort study
    Mary Margaret Chren
    Health Services Research and Development Service, Department of Veterans Affairs, San Francisco VA Medical Center 151R, 4150 Clement St, San Francisco, CA 94121, USA
    Arch Dermatol 147:540-6. 2011
    ..To determine long-term tumor recurrence rates after treatment of primary nonmelanoma skin cancer (NMSC). Data are currently insufficient to permit evidence-based choices among treatments for NMSC...
  5. pmc Interpretation of quality-of-life scores
    Mary Margaret Chren
    Department of Dermatology, University of California, San Francisco, San Francisco, California, USA
    J Invest Dermatol 130:1207-9. 2010
    ..The cutoff scores identify patients whose skin diseases severely affect their quality of life...
  6. ncbi request reprint Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma
    Mary Margaret Chren
    Dermatology Service, San Francisco Veterans Affairs Medical Center and the Department of Veterans Affairs, San Francisco, California 94121, USA
    J Invest Dermatol 127:1351-7. 2007
    ..2 (7.4, 12.9) after Mohs surgery, and 3.4 (-0.9, 7.6) after ED&C. We conclude that, for NMSC, quality-of-life outcomes were similar after excision and Mohs surgery, and both therapies had better outcomes than ED&C...
  7. ncbi request reprint Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma
    Tina Chen
    School of Medicine, University of California at San Francisco, San Francisco, USA
    Arch Dermatol 143:1386-92. 2007
    ..To identify predictors of skin-related quality of life (QOL) after treatment of nonmelanoma skin cancer (NMSC)...
  8. ncbi request reprint Variation in care for nonmelanoma skin cancer in a private practice and a veterans affairs clinic
    Mary Margaret Chren
    Dermatology Service, Research Enhancement Award Program of the Health Services Research and Development Service, Department of Veterans Affairs, San Francisco Veterans Affairs Medical Center, San Francisco, California 94121, USA
    Med Care 42:1019-26. 2004
    ..Clinical variables that may affect treatment choices can be identified, but little is known about how clinicians choose among therapies...
  9. ncbi request reprint Narrative review: the promotion of gabapentin: an analysis of internal industry documents
    Michael A Steinman
    San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California 94143, USA
    Ann Intern Med 145:284-93. 2006
    ..Such documents have become available through litigation concerning the promotion of gabapentin (Neurontin, Pfizer, Inc., New York, New York) for off-label uses...
  10. ncbi request reprint Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease
    ANN M O'HARE
    Department of Medicine, VA Medical Center, San Francisco, San Francisco, CA 94121, USA
    Clin J Am Soc Nephrol 1:297-304. 2006
    ..However, among patients with renal insufficiency, mortality is lowest for patients who receive a revascularization. Further studies are needed to determine the optimal care for this high-risk patient group...
  11. ncbi request reprint Cognitive screening predicts magnitude of functional recovery from admission to 3 months after discharge in hospitalized elders
    Laura P Sands
    UCSF Mt Zion Center on Aging and Department of Medicine, University of California, San Francisco, USA
    J Gerontol A Biol Sci Med Sci 58:37-45. 2003
    ..We sought to determine whether performance on a cognitive screen at the time of hospital admission predicted the magnitude of functional recovery after hospitalization...
  12. pmc Treatment of nonfatal conditions at the end of life: nonmelanoma skin cancer
    Eleni Linos
    Department of Dermatology, 2340 Sutter St, Room N421, Mail Code Box 0808, San Francisco, CA 94143 0808, USA
    JAMA Intern Med 173:1006-12. 2013
    ..Because NMSCs do not typically affect survival or short-term quality of life, the decision about whether and how to treat patients with limited life expectancy (LLE) is challenging, especially for asymptomatic tumors...
  13. pmc Patient satisfaction after treatment of nonmelanoma skin cancer
    Maryam M Asgari
    Division of Research, Kaiser Permanente Northern California, Oakland, California, USA
    Dermatol Surg 35:1041-9. 2009
    ..Patient satisfaction is an important aspect of patient-centered care but has not been systematically studied after treatment of nonmelanoma skin cancer (NMSC), the most prevalent cancer...
  14. pmc A clinical index to stratify hospitalized older adults according to risk for new-onset disability
    Kala M Mehta
    Division of Geriatrics, University of California at San Francisco, San Francisco, CA 94121, USA
    J Am Geriatr Soc 59:1206-16. 2011
    ..Thus, this study's objective was to develop and validate a clinical index to determine, at admission, risk for new-onset disability among older, hospitalized adults at discharge...
  15. pmc Variation in care for recurrent nonmelanoma skin cancer in a university-based practice and a veterans affairs clinic
    F Landon Clark
    Department of Dermatology, Stanford University MedicalCenter, Stanford, California, USA
    Arch Dermatol 144:1148-52. 2008
    ..To learn if treatment of recurrent nonmelanoma skin cancer (NMSC) varied in different practice settings...
  16. ncbi request reprint International Prevalence of Indoor Tanning: A Systematic Review and Meta-analysis
    Mackenzie R Wehner
    Department of Dermatology, University of California, San Francisco2Stanford University School of Medicine, Stanford, California3Department of Public Health and Primary Care, University of Cambridge, Cambridge, England
    JAMA Dermatol 150:390-400. 2014
    ..Given the large number of skin cancer cases attributable to indoor tanning, these findings highlight a major public health issue. ..
  17. pmc Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma
    Maryam M Asgari
    Division of Research, Kaiser Permanente Northern California, Oakland, California, USA
    J Invest Dermatol 130:1438-43. 2010
    ..11). Our findings suggest that higher prediagnostic serum 25(OH)D levels may be associated with increased risk of subsequent BCC. Further studies to evaluate the effect of sun exposure on BCC and serum 25(OH)D levels may be warranted...
  18. ncbi request reprint Skin-related quality of life in HIV-infected patients on highly active antiretroviral therapy
    Paradi Mirmirani
    Department of Dermatology, University of California, San Francisco, California 94143 0316, USA
    J Cutan Med Surg 6:10-5. 2002
    ..The overall health status and survival of HIV-infected patients has changed with the advent of highly active antiretroviral therapy (HAART). With this improved survival, there is a greater urgency to study quality-of-life issues...
  19. pmc Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting
    Leslie S Wilson
    University of California at San Francisco, San Francisco, California 94013, USA
    Dermatol Surg 38:570-84. 2012
    ..To compare fees for biopsy, treatment procedure, repair, and 2-month follow-up for nonmelanoma skin cancer (NMSC) treatments: electrodesiccation and curettage (ED&C), excision, and Mohs micrographic surgery (MMS)...
  20. pmc Sun protective behaviors and vitamin D levels in the US population: NHANES 2003-2006
    Eleni Linos
    Department of Dermatology, Stanford University School of Medicine, Pavilion B 2nd Floor, 450 Broadway St, Redwood City, CA 94063, USA
    Cancer Causes Control 23:133-40. 2012
    ..Our aim was to investigate the relationship between different types of sun protective behaviors and serum 25(OH)D levels in the general US population...
  21. pmc Adaptation of a Runyankore version of Skindex-16 for oral administration in Mbarara, Uganda
    Ser Ling Chua
    Department of Dermatology, University of California, San Francisco, CA, USA
    Int J Dermatol 50:1249-54. 2011
    ..Little is known about the feasibility of using adaptations of validated instruments in situations where literacy rates are low...
  22. pmc Supplement use and risk of cutaneous squamous cell carcinoma
    Maryam M Asgari
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94612, USA
    J Am Acad Dermatol 65:1145-51. 2011
    ..Laboratory and epidemiologic studies suggest that certain dietary supplements may alter risk of cutaneous squamous cell carcinoma (SCC)...
  23. pmc Itch as a patient-reported symptom in ambulatory care visits in the United States
    Melissa Shive
    School of Medicine, University of California, San Francisco, California Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts
    J Am Acad Dermatol 69:550-6. 2013
    ..European studies have shown that itch is a widespread symptom, yet little is known about its frequency in the United States...
  24. doi request reprint Out of the skin of babes: measuring the full impact of atopic dermatitis in infants and young children
    Amy S Paller
    Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N Street Clair, Suite 1600, Chicago, Illinois 60611, USA
    J Invest Dermatol 132:2494-6. 2012
    ..The work emphasizes that psychometric measurement continues to develop and reminds us that optimal care of children with atopic dermatitis requires considering its multidimensional effects on both the children and their families...
  25. ncbi request reprint Measurement of vital signs for skin diseases
    Mary Margaret Chren
    Department of Dermatology, University of California at San Francisco, San Francisco, California, USA
    J Invest Dermatol 125:viii-ix. 2005
  26. ncbi request reprint Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists
    Michael Shapiro
    Department of Dermatology, University of Pennsylvania School of Medicine, 3600 Spruce Street, Philadelphia, PA 19104, USA
    J Cutan Pathol 31:523-30. 2004
    ..A 1992 National Institutes of Health (NIH) Consensus Conference sought to unify nomenclature and suggested that the term "nevus with architectural disorder" be used along with a comment on melanocytic atypia...
  27. ncbi request reprint Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease
    ANN M O'HARE
    Division of Nephrology, Box 111J, Nephrology, VA Medical Center San Francisco, 4150 Clement Street, San Francisco, CA 94121, USA
    J Am Soc Nephrol 16:514-9. 2005
    ..Death rates were particularly high among those with a GFR <30 ml/min per 1.73 m(2). This finding may be partly explained by their more frequent presentation with ischemic ulceration or gangrene rather than rest pain...
  28. pmc Characteristics and impact of drug detailing for gabapentin
    Michael A Steinman
    Affairs Medical Center, San Francisco, California, United States of America
    PLoS Med 4:e134. 2007
    ..In this study, we evaluated the content and impact of detail visits for gabapentin by analyzing market research forms completed by physicians after receiving a detail visit for this drug...
  29. pmc Fitzpatrick skin phototype is an independent predictor of squamous cell carcinoma risk after solid organ transplantation
    Ravinder Gogia
    Department of Dermatology, University of California at San Francisco, San Francisco, California 94115, USA
    J Am Acad Dermatol 68:585-91. 2013
    ..In predominantly white cohorts, Fitzpatrick skin type (FST) has been reported to be a risk factor for developing posttransplantation skin cancers...
  30. pmc What's in a name? Use of brand versus generic drug names in United States outpatient practice
    Michael A Steinman
    Division of Geriatrics, San Francisco VA Medical Center and the University of California, San Francisco, CA 94121, USA
    J Gen Intern Med 22:645-8. 2007
    ..The use of brand rather than generic names for medications can increase health care costs. However, little is known at a national level about how often physicians refer to drugs using their brand or generic names...
  31. pmc Effects of vulvodynia on quality of life
    Maya Ponte
    School of Medicine, University of California San Francisco, San Francisco, California, USA
    J Am Acad Dermatol 60:70-6. 2009
    ..The experiences of women with vulvodynia are poorly understood...
  32. ncbi request reprint A pilot quality-of-life instrument for acne rosacea
    Kimberly Nicholson
    Department of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA
    J Am Acad Dermatol 57:213-21. 2007
    ..No rosacea-specific quality-of-life (QOL) instrument exists...
  33. ncbi request reprint Determining the value of surgical therapies for basal cell carcinoma
    Mary Margaret Chren
    Arch Dermatol 142:231-2. 2006
  34. ncbi request reprint Conceptual issues in measuring the burden of skin diseases
    Mary Margaret Chren
    J Investig Dermatol Symp Proc 9:97-100. 2004
  35. ncbi request reprint Childhood Atopic Dermatitis Impact Scale: reliability, discriminative and concurrent validity, and responsiveness
    Sarah L Chamlin
    Division of Pediatric Dermatology, Children s Memorial Hospital, Chicago, IL 60614, and Center on Outcomes Research and Education, Evanston Northwestern Healthcare and Northwestern Feinberg School of Medicine, USA
    Arch Dermatol 143:768-72. 2007
    ..To evaluate the test-retest reliability, discriminative and concurrent validity, and responsiveness of the Childhood Atopic Dermatitis Impact Scale (CADIS), a quality-of-life scale with 5 domains...
  36. ncbi request reprint The Japanese version of Skindex-16: a brief quality-of-life measure for patients with skin diseases
    Yuko Higaki
    Department of Dermatology, Tokyo Women s Medical University, Tokyo, Japan
    J Dermatol 29:693-8. 2002
    ..In conclusion, we have developed a semantically equivalent translation of Skindex-16 into Japanese. It is a reliable and valid measure of the effects of skin disease on the quality of life in Japanese patients...
  37. ncbi request reprint Scalpdex: a quality-of-life instrument for scalp dermatitis
    Suephy C Chen
    Department of Dermatology and Emory Center for Outcomes Research, Atlanta, GA 30033, USA
    Arch Dermatol 138:803-7. 2002
    ..To develop a scalp dermatitis-specific quality-of-life instrument...
  38. ncbi request reprint Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions
    Francesca Sampogna
    Dermatological Institute IDI IRCCS, Rome, Italy
    Psychosom Med 66:620-4. 2004
    ..To determine the relationship between skin-related quality of life and psychiatric morbidity in patients with different skin conditions...
  39. ncbi request reprint Effects of atopic dermatitis on young American children and their families
    Sarah L Chamlin
    Division of Pediatric Dermatology, Children s Memorial Hospital, Chicago, Illinois, USA
    Pediatrics 114:607-11. 2004
    ..This study was conducted to document these effects of atopic dermatitis on young children and their families...
  40. ncbi request reprint Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma
    Maryam Asgari
    Division of Dermatology, University of Washington Medical Center, Seattle, Washington 98195, USA
    Dermatol Surg 30:1335-42. 2004
    ..Nonsteroidal anti-inflammatory drugs are widely reported to inhibit carcinogenesis...
  41. ncbi request reprint The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis
    Sarah L Chamlin
    Division of Pediatric Dermatology at Children s Memorial Hospital, Chicago, IL, USA
    Arch Pediatr Adolesc Med 159:745-50. 2005
    ..Sleep characteristics in young children with atopic dermatitis and their families have not been thoroughly investigated...
  42. ncbi request reprint Evaluating clinical rating scales for evidence-based dermatology: some basic concepts
    Madhulika A Gupta
    Department of Psychiatry, University of Western Ontario, London, ON, Canada
    Dermatol Clin 23:703-6. 2005
    ..Also discussed is the impact of these parameters on increasing the statistical power of a clinical trial...
  43. ncbi request reprint Development of the Childhood Atopic Dermatitis Impact Scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families
    Sarah L Chamlin
    Division of Pediatric Dermatology, Children s Memorial Hospital, Chicago, Illinois, USA
    J Invest Dermatol 125:1106-11. 2005
    ..Seventeen items were eliminated, yielding a 45-item refined version of CADIS (score 0-180) with evidence of content and construct validity and suggested use in clinical research...
  44. ncbi request reprint Testing and reducing skindex-29 using Rasch analysis: Skindex-17
    Tamar E C Nijsten
    Department of Dermatology, Erasmus Medical Center, Rotterdam, The Netherlands
    J Invest Dermatol 126:1244-50. 2006
    ..The Skindex-17 is a Rasch reduced version of Skindex-29, with two independent scores that can be used in the measurement of HRQOL in dermatological patients...
  45. ncbi request reprint Turkish version of Skindex-29
    Ayse Esra Koku Aksu
    Department of Dermatology, Osmangazi University Medical School, Eskisehir, Turkey
    Int J Dermatol 46:350-5. 2007
    ..Most of the existing dermatology-specific measures were developed for the English language, and these measures should be adapted for use in other cultures...
  46. ncbi request reprint Doctor's orders: rethinking compliance in dermatology
    Mary Margaret Chren
    Arch Dermatol 138:393-4. 2002

Research Grants8

  1. COMPREHENSIVE OUTCOME OF NONMELANOMA SKIN CANCER
    Mary Margaret Chren; Fiscal Year: 2005
    ..abstract_text> ..
  2. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2006
    ..The results will also provide a basis for planning controlled trials of different treatments of NMSC, to guide decisions about the use of resources for this common tumor. ..
  3. Patient-Oriented Research in Skin Diseases
    Mary Margaret Chren; Fiscal Year: 2007
    ..Chren to broaden the scope of her on-going research as well as formalize an explicit mentoring arrangement for developing new patient-oriented investigators in skin diseases. ..
  4. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2007
    ..The results will also provide a basis for planning controlled trials of different treatments of NMSC, to guide decisions about the use of resources for this common tumor. ..
  5. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2009
    ..The results will also provide a basis for planning controlled trials of different treatments of NMSC, to guide decisions about the use of resources for this common tumor. ..
  6. Long-Term Outcomes of Nonmelanoma Skin Cancer
    Mary Margaret Chren; Fiscal Year: 2009
    ..The results will also provide a basis for planning controlled trials of different treatments of NMSC, to guide decisions about the use of resources for this common tumor. ..